BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16196472)

  • 21. Novel Perspectives in Medicinal Chemistry.
    Norman P
    Drug News Perspect; 2002 Jun; 15(5):313-320. PubMed ID: 12677227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
    Baillie TA
    Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 10th Joint Meeting on Medicinal Chemistry (JMMC 2017) Held in Dubrovnik, Croatia.
    Perković I; Stepanić V; Marković VG
    ChemMedChem; 2018 Jan; 13(1):116-119. PubMed ID: 29251431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Society for Anti-infective Pharmacology--Ninth International Symposium. 3-4 July 1999, Birmingham, UK.
    Witty D
    IDrugs; 1999 Sep; 2(9):874-6. PubMed ID: 16121300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease Inhibition: Design, Technology & Opportunities--First RSC/SCI Symposium on Protease Inhibition.18-19 May 1998, London, UK.
    Buckle DR
    IDrugs; 1998 Jun; 1(2):185-8. PubMed ID: 18465527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successes and pitfalls of medical chemistry programs.
    Norman P
    Drug News Perspect; 2001 Nov; 14(9):551-67. PubMed ID: 12806443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Chemical Biology-Medicinal Chemistry Continuum: EFMC's Vision.
    Duca M; Gillingham D; Olsen CA; Sbardella G; Skaanderup PR; van der Stelt M; Vauzeilles B; Vázquez O; Auberson YP
    Chembiochem; 2021 Oct; 22(19):2823-2825. PubMed ID: 34347337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Royal Society of Chemistry--sixth international symposium on applied bioinorganic chemistry.
    Taylor DM
    IDrugs; 2001 Sep; 4(9):1005-7. PubMed ID: 15965842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural Products as a Source of New Drugs.
    Norman P
    Drug News Perspect; 2002 Sep; 15(7):461-465. PubMed ID: 12677183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes.
    Quancard J; Cox B; Finsinger D; Guéret SM; Hartung IV; Koolman HF; Messinger J; Sbardella G; Laufer S
    ChemMedChem; 2020 Dec; 15(24):2388-2390. PubMed ID: 32881363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of combinatorial chemistry to speed drug discovery.
    Rádl S
    Drug News Perspect; 1998 Oct; 11(8):507-11. PubMed ID: 15616678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges facing drug discovery in vascular disease.
    Cowley P; Witherington J
    Drug News Perspect; 2005 Dec; 18(10):657-62. PubMed ID: 16491168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imidazole receptors. 22-24 July 1998, Bonn, Germany.
    Head GA
    IDrugs; 1998 Oct; 1(6):643-6. PubMed ID: 18465612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies and techniques for identification of novel bioactive compounds--CHI's second annual conference. 7-9 October 1998, Zurich, Switzerland.
    Kubinyi H
    IDrugs; 1998 Dec; 1(8):883-6. PubMed ID: 16196479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International Society of Heterocyclic Chemistry--17th international congress. 1-6 August 1999, Vienna, Austria.
    Daneshtalab M
    IDrugs; 1999 Oct; 2(10):998-1001. PubMed ID: 16118707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Back in Person: Frontiers in Medicinal Chemistry 2023.
    Gehringer M; Pape F; Méndez M; Barbie P; Unzue Lopez A; Lefranc J; Klingler FM; Hessler G; Langer T; Diamanti E; Schiedel M
    ChemMedChem; 2023 Oct; 18(19):e202300344. PubMed ID: 37485831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Young Scientists Network: How the European Federation for Medicinal Chemistry (EFMC) Became Young Again.
    Goncharenko K; Mari M; Auberson YP; Matagne B
    ChemMedChem; 2020 Dec; 15(24):2359-2362. PubMed ID: 33197135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteolytic enzymes as therapeutic targets - Keystone Symposium. 3-8 February 2002, Keystone, CO, USA.
    Creemers J
    IDrugs; 2002 Mar; 5(3):216-9. PubMed ID: 15562329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing candidate selection--a vision in business limited conference. 1-2 December 1998, Basel, Switzerland.
    Audus KL
    IDrugs; 1999 Feb; 2(2):91-3. PubMed ID: 16160941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.